Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension
PS Douglas
and
B Tallant
Cardiovascular Section, Hospital of the University of Pennsylvania, Philadelphia.
To examine the relations among hypertrophy, fibrosis and diastolic performance in early experimental hypertension, 18 control dogs and 12 dogs with experimental left ventricular hypertrophy were studied. Diastolic function was impaired in dogs with left ventricular hypertrophy, with decreased Doppler early to atrial inflow velocity ratio (E/A) (1.35 versus 1.72), increased atrial filling fraction (35% versus 29%), decreased sonomicrometric peak rates of wall thinning (-2.01 versus -3.37 liters/s) and filling (4.33 versus 6.64 liters/s) and prolonged time constant of isovolumetric relaxation (tau; 34.3 versus 28.1 ms). Neither chamber stiffness (k; P = AekV) nor passive elastic stiffness (E; E = k sigma, where sigma = stress) was increased. At postmortem examination, the hypertensive left ventricle weighed significantly more than normal (116 versus 80 g; p less than 0.01) and had greater muscle fiber diameter at endocardial and epicardial sampling sites in the apical free wall, basal free wall and septum (mean diameter 50 +/- 8 microns in hypertensive dogs, 37 +/- 8 microns in normal dogs; p less than 0.01). In contrast, neither percent fibrosis (1.2 +/- 0.8 versus 0.9 +/- 0.6 in normal dogs) nor fibrotic volume (1.21 +/- 0.63 versus 0.72 +/- 0.42%/g in normal dogs) was significantly increased. Peak volumetric filling rate was inversely related to fiber diameter (r = -0.74, p less than 0.001), although no variable of left ventricular function was significantly related to percent or volume fibrosis (all r less than 0.60, all p greater than 0.05). Thus, diastolic dysfunction may exist in the setting of hypertrophy without significant fibrosis. Increased myocyte size was associated with early diastolic filling abnormalities characteristic of the hypertensive left ventricle. Fibrosis appears to be a less important determinant of diastolic performance.
This article has been cited by other articles:

|
 |

|
 |
 
G. L. Brower, J. D. Gardner, M. F. Forman, D. B. Murray, T. Voloshenyuk, S. P. Levick, and J. S. Janicki
The relationship between myocardial extracellular matrix remodeling and ventricular function.
Eur. J. Cardiothorac. Surg.,
October 1, 2006;
30(4):
604 - 610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stowasser, J. Sharman, R. Leano, R. D. Gordon, G. Ward, D. Cowley, and T. H. Marwick
Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
J. Clin. Endocrinol. Metab.,
September 1, 2005;
90(9):
5070 - 5076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Funabiki, K. Onishi, K. Dohi, T. Koji, K. Imanaka-Yoshida, M. Ito, H. Wada, N. Isaka, T. Nobori, and T. Nakano
Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2487 - H2492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Henriques-Coelho, J. Correia-Pinto, R. Roncon-Albuquerque Jr, M. J. Baptista, A. P. Lourenco, S. M. Oliveira, A. Brandao-Nogueira, A. Teles, J. M. Fortunato, and A. F. Leite-Moreira
Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2885 - H2890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Henik, R. L. Stepien, and H. B. Bortnowski
Spectrum of M-Mode Echocardiographic Abnormalities in 75 Cats With Systemic Hypertension
J. Am. Anim. Hosp. Assoc.,
September 1, 2004;
40(5):
359 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Komamura, R. Tatsumi, J.-i. Miyazaki, K. Matsumoto, E. Yamato, T. Nakamura, Y. Shimizu, T. Nakatani, S. Kitamura, H. Tomoike, et al.
Treatment of Dilated Cardiomyopathy With Electroporation of Hepatocyte Growth Factor Gene Into Skeletal Muscle
Hypertension,
September 1, 2004;
44(3):
365 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Mottram, B. Haluska, R. Leano, D. Cowley, M. Stowasser, and T. H. Marwick
Effect of Aldosterone Antagonism on Myocardial Dysfunction in Hypertensive Patients With Diastolic Heart Failure
Circulation,
August 3, 2004;
110(5):
558 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Piech, P. E. Massart, C. Dessy, O. Feron, X. Havaux, N. Morel, J.-L. Vanoverschelde, J. Donckier, and J.-L. Balligand
Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy
Am J Physiol Heart Circ Physiol,
January 1, 2002;
282(1):
H219 - H231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Nagaya, M. Uematsu, M. Kojima, Y. Ikeda, F. Yoshihara, W. Shimizu, H. Hosoda, Y. Hirota, H. Ishida, H. Mori, et al.
Chronic Administration of Ghrelin Improves Left Ventricular Dysfunction and Attenuates Development of Cardiac Cachexia in Rats With Heart Failure
Circulation,
September 18, 2001;
104(12):
1430 - 1435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y.T. Hart, D. M. Meyer, H. D. Tazelaar, J. P. Grande, J. C. Burnett Jr, P. R. Housmans, and M. M. Redfield
Load Versus Humoral Activation in the Genesis of Early Hypertensive Heart Disease
Circulation,
July 10, 2001;
104(2):
215 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. I Jugdutt and M. Balghith
Enhanced regional AT2-receptor and PKC{varepsilon} expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction
Journal of Renin-Angiotensin-Aldosterone System,
June 1, 2001;
2(2):
134 - 140.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cittadini, J. D. Grossman, H. Stromer, S. E. Katz, J. P. Morgan, and P. S. Douglas
Importance of an Intact Growth Hormone/Insulin-Like Growth Factor 1 Axis for Normal Post-Infarction Healing: Studies in Dwarf Rats
Endocrinology,
January 1, 2001;
142(1):
332 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Masuyama, K. Yamamoto, Y. Sakata, R. Doi, N. Nishikawa, H. Kondo, K. Ono, T. Kuzuya, M. Sugawara, and M. Hori
Evolving changes in Doppler mitral flow velocity pattern in rats with hypertensive hypertrophy
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2333 - 2338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Yi Xu, V. Menon, and B. I Jugdutt
Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-{varepsilon} in acutely reperfused myocardial infarction in the dog: Effect of UP269-6 and losartan on AT1- and AT2-receptor expression and IP3 receptor and PKC{varepsilon} proteins
Journal of Renin-Angiotensin-Aldosterone System,
June 1, 2000;
1(2):
184 - 195.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S F De Marchi, Y Allemann, and C Seiler
Relaxation in hypertrophic cardiomyopathy and hypertensive heart disease: relations between hypertrophy and diastolic function
Heart,
June 1, 2000;
83(6):
678 - 684.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. I. Jugdutt, Yi Xu, M. Balghith, R. Moudgil, and V. Menon
Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKC{varepsilon} Proteins and cGMP
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 2000;
5(4):
301 - 311.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tamirisa, K. J. Blumer, and A. J. Muslin
RGS4 Inhibits G-Protein Signaling in Cardiomyocytes
Circulation,
January 26, 1999;
99(3):
441 - 447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Zile, K. Richardson, M. K. Cowles, J. M. Buckley, M. Koide, B. A. Cowles, V. Gharpuray, and G. Cooper IV
Constitutive Properties of Adult Mammalian Cardiac Muscle Cells
Circulation,
August 11, 1998;
98(6):
567 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.N. Jyothirmayi, B.J. Soni, M. Masurekar, M. Lyons, and T.J. Regan
Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 1998;
3(4):
319 - 326.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cittadini, H. Stromer, D. E. Vatner, J. D. Grossman, S. E. Katz, R. Clark, J. P. Morgan, and P. S. Douglas
Consequences of Growth Hormone Deficiency on Cardiac Structure, Function, and {beta}-Adrenergic Pathway: Studies in Mutant Dwarf Rats
Endocrinology,
December 1, 1997;
138(12):
5161 - 5169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Hayashida, J. Donckier, H. Van Mechelen, A. A. Charlier, and H. Pouleur
Diastolic properties in canine hypertensive left ventricular hypertrophy: Effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade
Cardiovasc Res,
January 1, 1997;
33(1):
54 - 62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jain, G. Avendano, S. Dharamsey, A. Dasmahapatra, R. Agarwal, A. Reddi, and T. Regan
Left Ventricular Diastolic Function in Hypertension and Role of Plasma Glucose and Insulin : Comparison With Diabetic Heart
Circulation,
April 1, 1996;
93(7):
1396 - 1402.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Cittadini, H. Stromer, S. E. Katz, R. Clark, A. C. Moses, J. P. Morgan, and P. S. Douglas
Differential Cardiac Effects of Growth Hormone and Insulin-like Growth Factor1 in the Rat : A Combined In Vivo and In Vitro Evaluation
Circulation,
February 15, 1996;
93(4):
800 - 809.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Miura, T. Hiramatsu, J. M. Forbess, and J. E. Mayer Jr
Effects of Elevated Coronary Sinus Pressure on Coronary Blood Flow and Left Ventricular Function : Implications After the Fontan Operation
Circulation,
November 1, 1995;
92(9):
298 - 303.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. E. Litwin, S. E. Katz, E. O. Weinberg, B. H. Lorell, G. P. Aurigemma, and P. S. Douglas
Serial Echocardiographic-Doppler Assessment of Left Ventricular Geometry and Function in Rats With Pressure-Overload Hypertrophy : Chronic Angiotensin-Converting Enzyme Inhibition Attenuates the Transition to Heart Failure
Circulation,
May 15, 1995;
91(10):
2642 - 2654.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Asif, J. Egan, S. Vasan, G. N. Jyothirmayi, M. R. Masurekar, S. Lopez, C. Williams, R. L. Torres, D. Wagle, P. Ulrich, et al.
An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness
PNAS,
March 14, 2000;
97(6):
2809 - 2813.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|